Welcome to our dedicated page for GOODNESS GROWTH HLDGS news (Ticker: GDNSF), a resource for investors and traders seeking the latest updates and insights on GOODNESS GROWTH HLDGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GOODNESS GROWTH HLDGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GOODNESS GROWTH HLDGS's position in the market.
Goodness Growth Holdings has announced a definitive agreement to acquire the assets of Charm City Medicus in Baltimore, Maryland, for a total of $8 million. The payment structure includes $4 million in cash, $2 million in stock, and a $2 million promissory note. This acquisition aims to enhance Goodness Growth's retail presence in Maryland's medical cannabis market, leveraging its Green Goods™ brand. The transaction is expected to close later this year, pending regulatory approval from the Maryland Medical Cannabis Commission.
Goodness Growth Holdings announced on June 28, 2021, that its subsidiary, Resurgent Biosciences, has filed a U.S. patent for a suite of virtual reality (VR) applications aimed at enhancing psychedelic-based therapies. This initiative addresses the need for a scalable platform for remote administration of psychedelic medicine. Collaborating with Cubicle Ninjas, Resurgent plans to develop customizable VR applications that support preparation and integration phases for patients, potentially optimizing therapeutic outcomes. Prototypes are expected by year-end.
Goodness Growth Holdings, Inc. (CSE: GDNS; OTCQX: GDNSF) announced on June 9, 2021, that its subsidiary Resurgent Biosciences will expand into psychedelic medicine research and intellectual property development. Resurgent is not involved in the cultivation or distribution of psychedelics but aims to conduct clinical research to enhance mental health treatment. The company also launched its TerpSafe™ packaging technology across North America, preserving 100% of terpene content for cannabis products. This strategic shift aims to create value for shareholders.